Jane Street Group, LLC Aptorum Group LTD Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.14 - $12.9 $13,239 - $149,820	11,614 New	11,614 $13,000
Q3 2022 Nov 14, 2022	BUY	$1.14 - $12.9 $13,239 - $149,820	11,614 New	11,614 $13,000
Q3 2021 Nov 16, 2021	SELL	$2.39 - $3.22 $128,154 - $172,659	-53,621 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.37 - $3.43 $127,081 - $183,920	53,621 New	53,621 $171,000
Q4 2020 Feb 17, 2021	SELL	$2.03 - $2.89 $22,480 - $32,003	-11,074 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.22 - $4.76 $13,510 - $52,712	11,074 New	11,074 $30,000

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $28.1M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.